BioCentury
ARTICLE | Clinical News

Aggrastat tirofiban regulatory update

September 21, 2015 7:00 AM UTC

Medicure submitted an sNDA to FDA for Aggrastat tirofiban to treat patients with ST segment elevation myocardial infarction (MI). The company expects a PDUFA date in July 2016. The non-peptide integr...